The Global Health and Economic Burden of Hospitalizations for Heart Failure
2014 · Journal of the American College of Cardiology · 1,999 citations
https://doi.org/10.1016/j.jacc.2013.11.053
A
Andrew P. Ambrosy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
371
Papers
12.3K
Citations
45
h-index
132
i10-index
Andrew P. Ambrosy is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Heart Failure Treatment and Management & Cardiovascular Function and Risk Factors & Cardiac pacing and defibrillation studies. The author has an h-index of 45, co-authored 316 publications.
ORCID: 0000-0002-4563-1071Papers by this author
worksAlbiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
2018 · The Lancet · 1,728 citations
https://doi.org/10.1016/s0140-6736(18)32261-x
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction
2020 · JACC Heart Failure · 55 citations
https://doi.org/10.1016/j.jchf.2020.05.005
Effect of Medically Tailored Meals on Clinical Outcomes in Recently Hospitalized High-Risk Adults
2022 · Medical Care · 39 citations
https://doi.org/10.1097/mlr.0000000000001759
Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure
2018 · Circulation · 34 citations
https://doi.org/10.1161/circulationaha.118.034668
A randomized trial of icosapent ethyl in ambulatory patients with COVID-19
2021 · iScience · 28 citations
https://doi.org/10.1016/j.isci.2021.103040
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat